Latest stories on ENVB
Enveric receives Notice of Allowance from USPTO for application for EVM401
The Fly63 · neutralgeneral
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
StockTitan55 · neutralgeneral
Psychedelic: Enveric, Helus, Bright Minds report earnings results
The Fly50 · neutralearnings
Enveric Biosciences GAAP EPS of -$0.76
Seeking Alpha28 · bearishearnings
Enveric Biosciences, Inc. (ENVB) files 8-K
SEC 8-K50 · neutralgeneral
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
StockTitan34 · bearishearnings
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
StockTitan63 · neutralproduct/pr
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
StockTitan67 · bullishgeneral
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit | ENVB Stock News
StockTitan56 · neutralproduct/pr
Enveric Biosciences Announces Participation in 2026 BIO International Convention | ENVB Stock News
StockTitan63 · neutralproduct/pr
Enveric Biosciences Expands At-The-Market Equity Offering
TipRanks28 · bearishgeneral
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day | ENVB Stock News
StockTitan55 · neutralgeneral
Enveric Biosciences Releases Updated Investor Presentation Materials
TipRanks55 · neutralgeneral
Enveric Biosciences, Inc. (ENVB) files 8-K
SEC 8-K50 · neutralgeneral
Enveric Biosciences GAAP EPS of -$1.08
Seeking Alpha28 · bearishearnings
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026
Morningstar50 · neutralearnings